To create Apple Tree Pharmaceuticals, ATP will combine the pragmatism of its proven, entrepreneurial asset development process with pharmaceutical industry sophistication. Apple Tree Pharmaceuticals is in the process of hiring a best-in-industry group of executives to guide the in-licensing, development and commercialization of its pipeline. The start up team of Apple Tree Pharmaceuticals is based in the ATP offices in New York, NY.
News & Events
- March 21 2013
Titan Pharmaceuticals Announces FDA Advisory Committee Recommends Approval of Probuphine® - March 12 2013
HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock - March 11 2013
HeartWare International, Inc. Announces Public Offering of Common Stock - March 4 2013
Tokai Pharmaceuticals to Present Data on Galeterone in Advanced Prostate Cancer at 2013 International Congress on Targeted Anticancer Therapies (TAT) - February 27 2013
Titan announces date of FDA Advisory Committee Review of PROBUPHINE® for the Treatment of Opioid Dependence 